ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Sanofi Complete list of announcements declared & dividend announcements by Sanofi GCVRZ

Sanofi GCVRZ listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sanofi GCVRZ

CORONA remedies buys Sanofi India's ortho brand Myoril
Ahmedabad-based pharmaceutical company CORONA Remedies has acquired the muscle relaxant brand Myoril from Sanofi India for Rs234 crore. The acquisition includes Myoril and its extensions. This acquisition comes after Corona's previous acquisitions of drug
Announcement as on 28 June 2023

Sanofi (SNY) Gains But Lags Market: What You Should Know
In the latest trading session, Sanofi (SNY) closed at .67, marking a +0.36% move from the previous day. This change lagged the S&P 500's 1.15% gain on the day. Elsewhere, the Dow gained 0.63%, while the tech-heavy Nasdaq ad
Announcement as on 27 June 2023

Sanofi (SNY) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Sanofi (SNY) closed at .72, marking a +0.4% move from the previous day. This move outpaced the S&P 500's daily gain of 0.08%. Meanwhile, the Dow lost 0.68%, and the Nasdaq, a tech-heavy index,
Announcement as on 14 June 2023

Sanofi India (NSE:SANOFI) Price Target Increased by 7.84% to 7,241.87
The average one-year price target for Sanofi India (NSE:SANOFI) has been revised to 7,241.87 / share. This is an increase of 7.84% from the prior estimate of 6,715.17 dated May 10, 2023.The price target is an average of many targets provided by analysts. T
Announcement as on 13 June 2023

: FDA advisers vote in favor of AstraZeneca, Sanofi antibody for infant RSV protection
Advisers to the U.S. Food and Drug Administration voted unanimously Thursday to recommend a monoclonal antibody developed by Sanofi SNY and AstraZeneca AZN to protect infants from respiratory syncytial virus. RSV is a common respiratory virus that can caus
Announcement as on 08 June 2023

Announcements by Sanofi first page | Next page | Prev page |

GCVRZ Sanofi current price & indicator signals

Moving Averages for Sanofi

  • 5Day Average: 0.87
  • 12Day Average: 0.87
  • 20Day Average: 0.87
  • 50Day Average: 0.87
  • 100Day Average: 0.83
  • 150Day Average: 0.73
  • 200Day Average: 0.68

GCVRZ Indicators & signals

Indicator MACD (12,26,9)

0.84, 0.81, 0.05
Indicator MACD is in positive zone

Indicator ADX (14)

0, 28.57, 28.57
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 64
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GCVRZ Sanofi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Tue Mar 2020 0.87 0.87 to 0.88 0% 18.75 times
02 Mon Mar 2020 0.87 0.87 to 0.87 0% 0.55 times
28 Fri Feb 2020 0.87 0.87 to 0.88 0% 1.5 times
27 Thu Feb 2020 0.87 0.87 to 0.88 0% 5.49 times
26 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.2 times
25 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.24 times
24 Mon Feb 2020 0.87 0.86 to 0.87 0% 0.57 times
21 Fri Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
20 Thu Feb 2020 0.87 0.87 to 0.87 0% 0.09 times
19 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.28 times
18 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
17 Mon Feb 2020 0.87 0.87 to 0.87 0% 0 times

Videos related to: GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

 

Back to top